Predictors and long-term clinical outcomes of newly developed atrial fibrillation in patients with cardiac implantable electronic devices
暂无分享,去创建一个
[1] E. Benjamin,et al. Global epidemiology of atrial fibrillation , 2016, Nature Reviews Cardiology.
[2] E. Mathiesen,et al. Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010 , 2015, Heart.
[3] S. Solomon,et al. Risk factors for atrial fibrillation in patients with normal versus dilated left atrium (from the Atherosclerosis Risk in Communities Study). , 2014, The American journal of cardiology.
[4] G. Breithardt,et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial , 2014, European heart journal.
[5] Daniel R. Frisch,et al. Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices. , 2014, Heart rhythm.
[6] C. Murray,et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.
[7] J. Olgin,et al. Incident Atrial Fibrillation Among Asians, Hispanics, Blacks, and Whites , 2013, Circulation.
[8] O. Franco,et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. , 2013, European heart journal.
[9] G. Lip,et al. Recent developments in understanding epidemiology and risk determinants of atrial fibrillation as a cause of stroke. , 2013, The Canadian journal of cardiology.
[10] Luca Segreti,et al. Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier. , 2013, Journal of the American College of Cardiology.
[11] T. Chao,et al. Sinus node dysfunction in atrial fibrillation patients: the evidence of regional atrial substrate remodelling. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[12] J. Kalman,et al. Sinus node dysfunction and atrial fibrillation: two sides of the same coin? , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[13] Mark A Hlatky,et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.
[14] A. Capucci,et al. Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.
[15] G. Lamas,et al. The Influence of Atrial and Ventricular Pacing on the Incidence of Atrial Fibrillation: A Meta‐Analysis , 2011, Pacing and clinical electrophysiology : PACE.
[16] Jeroen J. Bax,et al. Prediction of atrial fibrillation in patients with an implantable cardioverter‐defibrillator and heart failure , 2010, European journal of heart failure.
[17] Dongfeng Qi,et al. The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.
[18] D. Levy,et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study , 2009, The Lancet.
[19] S. A. Christman,et al. Frequency, duration, and predictors of newly-diagnosed atrial fibrillation following dual-chamber pacemaker implantation in patients without a previous history of atrial fibrillation. , 2008, The American journal of cardiology.
[20] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[21] C. Israel,et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. , 2004, Journal of the American College of Cardiology.
[22] G. Lip,et al. Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project). , 2003, The American journal of cardiology.
[23] G. Lamas,et al. Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.
[24] G. Lamas,et al. Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) , 2003, Circulation.
[25] S. Connolly,et al. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. , 2001, Journal of the American College of Cardiology.
[26] D. Levy,et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.
[27] D. Levy,et al. Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects , 1993, Circulation.
[28] J. Clarke,et al. Medicine , 1907, Bristol medico-chirurgical journal.